<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CLORAZEPATE DIPOTASSIUM</span><br/>(klor-az'e-pate)<br/><span class="topboxtradename">Novoclopate <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename"> Tranxene, </span><span class="topboxtradename">Tranxene-SD<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">anxiolytic</span>; <span class="classification">sedative-hypnotic</span>; <span class="classification">anticonvulsant</span>; <span class="classification">benzodiazepine</span><br/><b>Prototype: </b>Lorazepam<br/><b>Pregnancy Category: </b>D<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>3.75 mg, 7.5 mg, 15 mg capsules and tablets; 11.25 mg, 22.5 mg long acting tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Anxiolytic qualitatively similar to lorazepam. It has depressant effects on the CNS, thus controlling anxiety associated with
         stress.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective in controlling anxiety and withdrawal symptoms of alcohol.</p>
<h1><a name="uses">Uses</a></h1>
<p>Management of anxiety disorders, short-term relief of anxiety symptoms, as adjunct in management of partial seizures, and
         symptomatic relief of acute alcohol withdrawal.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to clorazepate and other benzodiazepines; acute narrow-angle glaucoma; depressive neuroses, psychotic reactions,
         drug abusers. Safe use during pregnancy (category D), lactation, and in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Older adults; debilitated patients; hepatic disease; kidney disease.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Anxiety</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 15 mg/d h.s., may increase to 1560 mg/d in divided doses (max: 60 mg/d)<br/><br/><span class="indicationtitle">Acute Alcohol Withdrawal</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 30 mg followed by 3060 mg in divided doses (max: 90 mg/d), taper by 15 mg/d over 4 d to 7.515 mg/d until patient
               is stable<br/><br/><span class="indicationtitle">Partial Seizures</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 7.5 mg t.i.d.<br/><span class="rdage">Child:</span> <span class="rdroute">
<i>912 y:</i> PO</span> 3.757.5 mg b.i.d., may increase by no more than 3.75 mg/wk (max: 60 mg/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food to minimize gastric distress. Give antacid no less than 1 h before or 1 h after drug ingestion.</li>
<li>Ensure that sustained-release form of drug is not chewed or crushed. It must be swallowed whole.</li>
<li>Taper drug dose gradually over several days when drug is to be discontinued. Abrupt termination may lead to memory impairment,
            severe GI symptoms, muscle pain, restlessness, irritability, fatigue, insomnia.
         </li>
<li>Store in light-resistant container at 15°30° C (59°86° F) unless otherwise specified.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Allergic reactions. <span class="typehead">CV:</span> Hypotension. <span class="typehead">GI:</span> GI disturbances, abnormal liver function tests, xerostomia. <span class="typehead"> Hematologic:</span> Decreased Hct, blood dyscrasias. <span class="typehead">CNS:</span>
<span class="speceff-common">Drowsiness,</span> ataxia, dizziness, headache, paradoxical excitement, mental confusion, insomnia. <span class="typehead">Special Senses:</span> diplopia, blurred vision. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Alcohol</b> and other <span class="classification">cns depressants</span> compound CNS depression; clorazepate increases effects of <b>cimetidine,</b>
<b>disulfiram,</b> causing excessive sedation. <span class="typehead">Herbal:</span>
<b>Ginkgo</b> may decrease anticonvulsant effectiveness. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Decarboxylated in stomach; absorbed as active metabolite, desmethyldiazepam. <span class="typehead">Peak:</span> 1 h. <span class="typehead">Duration:</span> 24 h.  <span class="typehead">Distribution:</span>  Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver to oxazepam. <span class="typehead"> Elimination:</span> Excreted primarily in urine. <span class="typehead">Half-Life:</span> 30200 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Drowsiness, a common side effect, is more likely to occur at initiation of therapy and with dose increments on successive
            days.
         </li>
<li>Lab tests: Periodic blood counts and tests of liver and kidney function should be performed throughout therapy.</li>
<li>Monitor patient with history of cardiovascular disease in early therapy for drug-induced responses. If systolic BP drops more
            than 20 mm Hg or if there is a sudden increase in pulse rate, withhold drug and notify physician.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take drug as prescribed and do not change dose or abruptly stop taking the drug without physician's approval.</li>
<li>Do not self-dose with OTC drugs (cold remedies, sleep medications, antacids) without consulting physician.</li>
<li>Avoid driving and other potentially hazardous activities until reaction to drug is known.</li>
<li>Do not use alcohol and other CNS depressants while on clorazepate therapy.</li>
<li>If a woman becomes pregnant during therapy or intends to become pregnant, communicate with physician about the desirability
            of discontinuing the drug.
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>